Table: begin end state 1 32 cytoplasmic 33 52 transmembrane 53 62 non-cytoplasmic 63 80 transmembrane 81 87 cytoplasmic 88 109 transmembrane 110 125 non-cytoplasmic 126 143 transmembrane 144 154 cytoplasmic 155 178 transmembrane 179 183 non-cytoplasmic 184 211 transmembrane 212 222 cytoplasmic 223 241 transmembrane 242 276 non-cytoplasmic 277 296 transmembrane 297 300 cytoplasmic 301 320 transmembrane 321 335 cytoplasmic 336 356 transmembrane 357 361 non-cytoplasmic 362 385 transmembrane 386 428 cytoplasmic 429 450 transmembrane 451 451 non-cytoplasmic
Input: >BWI76_RS04555 MSTTDNAFPATIDPINTPKAPLKQRWWHILDNWKVGIIPLPLFLLAGGLIALDCLGGKLP SDIVVMVATLAFFGFACGEFGKRLPILGKLGAAAICATFIPSALVHYGLLPDVVVESTTK FYKSTNILYLYICCIIVGSIMSMNRTTLIQGFMRIFFPMLCGEIVGMVVGVGVGTALGLE PFQVFFFIVLPIMAGGVGEGAIPLSIGYAALMHMDQGVALGRVLPMVMLGSLTAIVIAGG LNQLGKRFPHLTGEGQLMPNRRNETHRETPAEGKMDVTTLASGALLAVLLYMLGMLGQKT IGLPAPVGMLFLAVLLKLVNGVSPRLQEGSQMVYKFFRTAVTYPILFAVGVAITPWQELV NAFTLTNLLVIISTVSALVATGFLVGKKIGMHPIDVAIVSCCQSGQGGTGDVAILTSGNR MNLMPFAQIATRIGGAINVSLGLLFLSHFLA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server